Trial
NCT00274105
SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Hypertension
Intervention
telmisartan
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-23